Theophylline Tablet, Extended Release
Pricing Report NDC 69367-415-01
Current Package Pricing Information
The current wholesale acquisition cost for Theophylline (anhydrous) (NDC 69367-415-01) is $1.39516 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Jan 14, 2026.
As a a human prescription drug provided by Westminster Pharmaceuticals, Llc, this medication is distributed in a 100 TABLET, EXTENDED RELEASE in 1 BOTTLE configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.
NADAC Pricing Summary
NADAC pricing snapshot for this package NDC
Acquisition Cost $1.39516 Per EA
Historical Pricing Trends & Acquisition Cost Benchmarks
The current wholesale price for (NDC ) is based on the most recent federal survey data. As this is a newer entry or has a stable pricing model, the chart below reflects the current established benchmark of $1.39516 per EA.
| Date | Unit Price | Unit | Source | Method | Rate |
|---|---|---|---|---|---|
| Jan 14, 2026 | $1.39516 | EA | C/I - Chain or Independent Pharmacy | Code 4 | G - Generic |
Pricing Methodology Legend
- Code 4: The NADAC was carried forward from the previous file.
Understanding NADAC Pricing Data
The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.
Important Price Distinction:
The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.
NADAC Pricing Data Last Updated on: June 17, 2026
